Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongsheng Yujin (Beijing) Biotechnology Co., Ltd. is a specialized biotechnology firm focused on the research, development, and production of in vitro diagnostic (IVD) reagents and instruments. Operating as a subsidiary of China National Biotec Group (CNBG) within the Sinopharm ecosystem, the company leverages advanced molecular biology techniques to provide solutions for infectious disease screening and precision medicine. Its product portfolio includes high-sensitivity PCR detection kits for pathogens such as Human papillomavirus (HPV) and SARS-CoV-2, as well as automated nucleic acid extraction systems. Zhongsheng Yujin serves hospitals, CDC centers, and research institutions, playing a vital role in public health surveillance and clinical diagnostics in China. The company is headquartered in the Beijing Daxing Bio-medicine Industry Park and maintains rigorous quality standards including GMP and ISO 13485 certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongsheng YuJin.